On this news, HealthEquity shares fell 17% on March 19, 2025.

Walgreens Boots Alliance Inc. shares ended Tuesday’s session down 1.1% after the drugstore chain reported ...

Royal Bank of Canada lifted their price objective on HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research note on Tuesday, December 10th. Mizuho started ...

Raymond James upgraded HealthEquity (NASDAQ:HQY) from Outperform to Strong Buy, setting a new price target of $115, slightly below the previous $120, citing confidence in the company’s ability to ...

Raymond James upgraded HealthEquity (HQY) to Strong Buy from Outperform with a price target of $115, down from $120. The firm upgrade the ...

Fintel reports that on March 25, 2025, Raymond James upgraded their outlook for HealthEquity (NasdaqGS ... VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 2,744K shares ...

HealthEquity stock’s recent year-to-date underperformance is partly due to its disclosure of fraud against some of its HSA customers and near-term investor concerns about recent management changes.

The firm currently has an overweight rating on the stock. Several other brokerages have also recently weighed in on HQY. Royal Bank of Canada boosted their target price on HealthEquity from $100. ...

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Healthequity with a $ ... also maintained a Buy rating on the stock with a $126.00 price target.